Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial

2021266 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: The Lancet

Volume 397, Issue 10273, pp. 499-509

Field-Weighted Citation Impact: 11.64